Current studies have shown that HNRNPA2B1 participates in gene processing and alternative splicing and is a negative regulator of human breast cancer metastasis by maintaining the balance of multiple genes and pathways [50, 51], and the relationship between HNRNPA2B1 and chemotherapy in breast cancer is not clear. Here, HNRNPA2B1 is linked to breast carcinoma.